Safety, Tolerability and Pharmacokinetics Study of AIR DNAse Administered by Inhalation to Healthy Adult Volunteers

Clinical trial NCT02605590 · COMPLETED

Trial details

NCT number: NCT02605590
Sponsor: Protalix
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis (CF)

Start date: 2015-12-01
Primary completion: 2016-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.